$10.51
-0.16-1.50%
À la fermeture: -
$10.51
0.000.00%
Après les heures de négociation: Oct 24, 4:00 PM EDT
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Enanta Pharmaceuticals Inc (NASDAQ:ENTA) a diminué lors de la dernière période de déclaration, augmentant de en baisse de 3.35M à 2.81M. Cela représente 10.2% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Enanta Pharma Corp (XNAS:ENTA) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 835.77K actions échangées par jour, il faudrait 3.37 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
2.81M
Intérêt à court terme %
10.2%
Jours de couverture
3.37
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ENTA | Enanta Pharmaceuticals, Inc. C | 10/15/2025 | 10/24/2025 | 10.20% | 27,599,121 | 2,814,736 | 835,768 | 3.37 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 09/30/2025 | 10/09/2025 | 12.14% | 27,599,121 | 3,350,309 | 2,021,887 | 1.66 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 09/15/2025 | 09/24/2025 | 14.16% | 20,124,121 | 2,848,661 | 206,730 | 13.78 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 08/29/2025 | 09/10/2025 | 14.08% | 20,124,121 | 2,833,975 | 143,358 | 19.77 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 08/15/2025 | 08/26/2025 | 14.34% | 20,124,121 | 2,884,903 | 144,673 | 19.94 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 07/31/2025 | 08/11/2025 | 13.57% | 20,122,779 | 2,731,581 | 196,572 | 13.9 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 07/15/2025 | 07/24/2025 | 12.24% | 20,122,779 | 2,463,124 | 157,567 | 15.63 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 06/30/2025 | 07/10/2025 | 12.05% | 20,122,779 | 2,423,818 | 138,920 | 17.45 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 06/13/2025 | 06/25/2025 | 12.42% | 20,122,779 | 2,498,915 | 237,356 | 10.53 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 05/30/2025 | 06/10/2025 | 13.53% | 20,122,779 | 2,721,617 | 105,008 | 25.92 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 05/15/2025 | 05/27/2025 | 14.19% | 20,122,779 | 2,854,687 | 134,930 | 21.16 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 04/30/2025 | 05/09/2025 | 14.73% | 20,078,742 | 2,957,157 | 181,451 | 16.3 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 04/15/2025 | 04/25/2025 | 13.96% | 20,078,742 | 2,803,726 | 315,454 | 8.89 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 03/31/2025 | 04/09/2025 | 13.28% | 20,078,742 | 2,667,145 | 201,024 | 13.27 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 03/14/2025 | 03/25/2025 | 13.11% | 20,078,742 | 2,632,482 | 262,336 | 10.03 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 02/28/2025 | 03/11/2025 | 12.94% | 20,078,742 | 2,598,257 | 523,491 | 4.96 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 02/14/2025 | 02/26/2025 | 17.79% | 20,078,742 | 3,572,627 | 603,837 | 5.92 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 01/31/2025 | 02/11/2025 | 16.76% | 20,078,742 | 3,364,560 | 366,653 | 9.18 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 01/15/2025 | 01/27/2025 | 16.22% | 19,933,548 | 3,232,743 | 741,016 | 4.36 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 12/31/2024 | 01/10/2025 | 16.79% | 19,933,548 | 3,347,388 | 717,663 | 4.66 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 12/13/2024 | 12/24/2024 | 16.91% | 19,933,548 | 3,371,327 | 575,287 | 5.86 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 11/29/2024 | 12/10/2024 | 16.21% | 19,933,548 | 3,231,310 | 311,534 | 10.37 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 11/15/2024 | 11/26/2024 | 16.95% | 19,927,793 | 3,378,684 | 100,767 | 33.53 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 10/31/2024 | 11/11/2024 | 17.26% | 19,927,793 | 3,440,099 | 122,820 | 28.01 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 10/15/2024 | 10/24/2024 | 17.20% | 19,927,793 | 3,427,004 | 184,142 | 18.61 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 09/30/2024 | 10/09/2024 | 14.98% | 19,927,793 | 2,985,735 | 212,865 | 14.03 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 09/13/2024 | 09/24/2024 | 14.64% | 19,927,793 | 2,917,239 | 124,692 | 23.4 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 08/30/2024 | 09/11/2024 | 14.61% | 19,927,793 | 2,910,550 | 126,851 | 22.94 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 08/15/2024 | 08/26/2024 | 14.84% | 19,927,793 | 2,957,765 | 190,993 | 15.49 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 07/31/2024 | 08/09/2024 | 14.05% | 19,927,793 | 2,800,039 | 129,943 | 21.55 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 07/15/2024 | 07/24/2024 | 14.61% | 19,918,622 | 2,910,636 | 224,224 | 12.98 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 06/28/2024 | 07/10/2024 | 15.12% | 19,918,622 | 3,012,010 | 224,860 | 13.4 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 06/14/2024 | 06/26/2024 | 13.84% | 19,918,622 | 2,755,876 | 225,212 | 12.24 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 05/31/2024 | 06/11/2024 | 13.85% | 19,918,622 | 2,759,266 | 128,111 | 21.54 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 05/15/2024 | 05/24/2024 | 14.06% | 19,918,622 | 2,800,265 | 138,343 | 20.24 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 04/30/2024 | 05/09/2024 | 13.96% | 19,918,622 | 2,781,478 | 134,485 | 20.68 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 04/15/2024 | 04/24/2024 | 13.80% | 19,895,205 | 2,744,555 | 205,130 | 13.38 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 03/28/2024 | 04/09/2024 | 13.79% | 19,895,205 | 2,742,991 | 301,497 | 9.1 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 03/15/2024 | 03/26/2024 | 12.11% | 19,895,205 | 2,409,754 | 207,613 | 11.61 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 02/29/2024 | 03/11/2024 | 10.48% | 19,895,205 | 2,085,486 | 209,676 | 9.95 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 02/15/2024 | 02/27/2024 | 11.11% | 19,895,205 | 2,209,504 | 298,823 | 7.39 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 01/31/2024 | 02/09/2024 | 9.25% | 19,895,205 | 1,840,415 | 243,174 | 7.57 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 01/12/2024 | 01/24/2024 | 9.76% | 16,329,123 | 1,593,413 | 396,445 | 4.02 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 12/29/2023 | 01/10/2024 | 9.50% | 16,329,123 | 1,550,818 | 156,440 | 9.91 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 12/15/2023 | 12/27/2023 | 11.01% | 16,329,123 | 1,798,411 | 232,512 | 7.73 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 11/30/2023 | 12/11/2023 | 9.00% | 16,329,123 | 1,469,536 | 345,771 | 4.25 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 11/15/2023 | 11/27/2023 | 9.22% | 16,329,123 | 1,505,578 | 319,851 | 4.71 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 10/31/2023 | 11/09/2023 | 8.18% | 16,325,590 | 1,336,144 | 273,459 | 4.89 |
À la recherche des actions les plus vendues à découvert?